Cardiovascular Research · 2004 · 46 citations · 22 references
MedicineCardiologyPharmacologyBiochemical PharmacologyMolecular PharmacologyPharmacodynamicsCardiac PhysiologyCardiovascular PhysiologyEndothelial DysfunctionHeart FailureHeart Failure Molecular MechanismsHeart Failure PhysiologyKinase InhibitorsMitogen-activated Protein Kinase KinaseMitogen-activated Protein Kinase SignalingP38 Mitogen-activated Protein Kinase SignalingVascular Endothelial DysfunctionVascular Endothelial Function
OBJECTIVE: The mitogen-activated protein (MAP) kinase system, especially the p38 MAP kinase, is activated in chronic heart failure (CHF). However, the role of vascular p38 MAP kinase in CHF has not been analyzed yet. METHODS AND RESULTS: In aortic rings from rats with CHF 10 weeks after myocardial infarction, acetylcholine-induced relaxation was attenuated (maximum relaxation, Rmax: 54+/-5%) compared to sham-operated animals (Rmax: 77+/-5%, p<0.01), while endothelium-independent relaxation elicited by sodium nitroprusside was not significantly changed. Aortic levels of phosphorylated p38 MAP kinase protein were significantly elevated in rats with CHF. In addition, phosphorylation of MAP kinase-activated protein kinase-2 (MAPKAPK-2), an index of p38 MAP kinase activity, was increased. Aortic superoxide anion generation was significantly enhanced in rats with CHF accompanied by elevation of the NAD(P)H oxidase subunit p47phox protein expression. Inhibition of p38 MAP kinase by treatment with the p38 MAP kinase inhibitor SB239063 (800 ppm in standard rat chow) reduced MAPKAPK-2 phosphorylation, preserved acetylcholine-induced relaxation (Rmax: 80+/-4%, p<0.01), and reduced vascular superoxide formation. SB239063 treatment did not affect blood pressure and left ventricular enddiastolic pressure. In aortic tissue from CHF animals treated with the angiotensin-converting enzyme (ACE) inhibitor trandolapril, p38 MAP kinase phosphorylation was significantly reduced. CONCLUSIONS: Vascular p38 MAP kinase is markedly activated in rats with CHF. Chronic p38 MAP kinase inhibition with SB239063 prevented endothelial vasomotor dysfunction through reduction of superoxide anion production.
22
Mechanisms Underlying Endothelial Dysfunction in Diabetes Mellitus
Ulrich Hink, Huige Li, Hanke Mollnau et al. · Circulation Research · 2001 · 1.2K citations
Medicine, Biochemistry, Pharmacology +16
Endothelium-dependent vasodilation is attenuated in patients with heart failure.
S H Kubo, Thomas S. Rector, Alan J. Bank et al. · Circulation · 1991 · 777 citations · Full text
Medicine, Pharmacology, Physiology +17
Masuko Ushio‐Fukai, R. Wayne Alexander, Marjorie Akers et al. · Journal of Biological Chemistry · 1998 · 653 citations · Full text